Fake drugs trade on the rise: EU

The trade in counterfeit medicines in the European Union has exceeded the body's worst fears, the European industry commissioner said on Monday.

The EU had seized 34 million fake tablets in just two months, Gunter Verheugen told German daily Die Welt - including antibiotics, cancer treatments and Viagra.

Verheugen said the European Commission was very concerned about the situation and said he expected the EU to take action to fight the menace of fake pharmaceuticals.

"The number of counterfeit medicines arriving in Europe ... is constantly growing. The European Commission is extremely worried," Verheugen said.

"In just two months, the EU seized 34 million fake tablets at customs points in all member countries. This exceeded our worst fears."

Other fake drugs seized included anti-malaria medicines, analgesics and anti-cholesterol treatments.

An EU report in July said that many of the fake pharmaceuticals seized in 2008 came from India.

Verheugen said counterfeiting drugs should be treated as a serious crime and punished severely.

"Every faked drug is a potential massacre. Even when a medicine only contains an ineffective substance, this can lead to people dying because they think they are fighting their illness with a real drug," Verheugen said.

"I expect the EU will agree in 2010 that a drug's journey from manufacture to sale should be scrutinised carefully. There will also be anti-counterfeit markings on packaging - in particular a barcode and seal, to show clearly if a package has been opened," he said.

In June, EU health ministers gave a warm reception to a legal proposal aimed at stopping fake drugs entering the legal supply chain.

The plan included more security measures on packaging, including barcodes, seals and holograms, as well as tighter controls on suppliers.

ak/pdw/bm

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in